Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S100B Protein in Non-traumatic Headaches
NCT02683304Completed
- Sponsor
- CHU Nîmes
- Start
- Mar 2017
- Primary completion
- Mar 2020
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by CHU Nîmes. Primary endpoints: S100B Protein Level at Day 0, Presence of Clinically Significant Anomaly on MRI and 1 more. Started Mar 2017; status: completed.
Beyond the preview
Go deeper on NCT02683304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02683304.